Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
504.6 INR | -0.49% | +2.27% | +3.14% |
Mar. 29 | Aarti Drugs Limited Announces Executive Cessation | CI |
Jan. 31 | Aarti Drugs Begins Manufacturing Dermatology Products in Tarapur, India Facility | MT |
Sales 2024 * | 26.12B 313M | Sales 2025 * | 29.48B 353M | Capitalization | 46.39B 556M |
---|---|---|---|---|---|
Net income 2024 * | 1.73B 20.74M | Net income 2025 * | 2.52B 30.15M | EV / Sales 2024 * | 1.78 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 1.57 x |
P/E ratio 2024 * |
27
x | P/E ratio 2025 * |
18.5
x | Employees | 1,003 |
Yield 2024 * |
0.93% | Yield 2025 * |
1.35% | Free-Float | 36.93% |
Latest transcript on Aarti Drugs Limited
1 day | -0.49% | ||
1 week | +2.27% | ||
Current month | +16.18% | ||
1 month | +16.18% | ||
3 months | -0.31% | ||
6 months | +7.11% | ||
Current year | +3.14% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Adhish P. Patil
DFI | Director of Finance/CFO | 41 | 12-07-05 |
Rushikesh Deole
CMP | Compliance Officer | - | 19-04-22 |
Members of the board | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 76 | 85-01-04 | |
Director/Board Member | 61 | 87-01-01 | |
Director/Board Member | 60 | 95-09-14 |
Date | Price | Change | Volume |
---|---|---|---|
24-04-30 | 504.6 | -0.49% | 77,440 |
24-04-29 | 507 | +0.58% | 122,695 |
24-04-26 | 504.2 | +0.79% | 73,241 |
24-04-25 | 500.2 | -0.11% | 68,793 |
24-04-24 | 500.8 | +0.18% | 76,028 |
Delayed Quote NSE India S.E., April 30, 2024 at 07:42 am EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
+33.25% | 704B | |
+28.59% | 577B | |
-3.55% | 348B | |
+18.16% | 327B | |
+4.36% | 288B | |
+14.81% | 234B | |
+4.93% | 198B | |
-9.78% | 194B | |
-3.69% | 147B |
- Stock Market
- Equities
- AARTIDRUGS Stock
- AARTIDRUGS Stock